MedPath

Effect of Oxymetazoline on septorhinoplasty surgery bleeding

Phase 2
Conditions
Bleeding in septorhinoplasty surgery.
Deviated nasal septum
J34.2
Registration Number
IRCT20230514058190N1
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
30
Inclusion Criteria

Candidate for septorhinoplasty surgery
ASA one or two
Consent to participate in the study

Exclusion Criteria

Being allergic to Oxymetazoline

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Bleeding rate. Timepoint: During septorhinoplasty surgery. Method of measurement: Measuring the blood in the suction device.;Systolic and diastolic blood pressure. Timepoint: Before induction of anesthesia, after intubation and at the end of surgery. Method of measurement: Monitoring device.;Heart rate. Timepoint: Before induction of anesthesia, after intubation and at the end of surgery. Method of measurement: Monitoring device.
Secondary Outcome Measures
NameTimeMethod
Surgeon's satisfaction with the surgical field. Timepoint: After completion of septorhinoplasty surgery. Method of measurement: According to the opinion of the surgeon who performed the septorhinoplasty surgery.
© Copyright 2025. All Rights Reserved by MedPath